Healthcare provider profile · identity verified

Christopher L Mauldin, MD

Allopathic & Osteopathic Physicians|Family Medicine · LAUREL, MS · NPI 1902831837

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Christopher L Mauldin, MD received $72.60 in general payments during 2025 across 4 reported records.

Salix Pharmaceuticals, a division of Bausch Health US, LLC accounted for 56.2% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 3 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Farxiga.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 99 claims for Linzess by this doctor in 2024.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LUMIGAN as an associated drug or biological on 25016 records involving 7645 distinct recipient NPIs. Public Medicare Part D data also shows 13 claims for Lumigan by this doctor in 2024.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 38 claims for Synthroid by this doctor in 2024.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported VRAYLAR as an associated drug or biological on 377741 records involving 62704 distinct recipient NPIs. Public Medicare Part D data also shows 17 claims for Vraylar by this doctor in 2024.

AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 268 claims for Farxiga by this doctor in 2024.

AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 26 claims for Symbicort by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$72.60

4 reported records · 3 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Salix Pharmaceuticals, a division of Bausch Health US, LLC	Unresolved — no canonical attribution shown	$40.84	56.2%	2	2025
ABBVIE INC.	Unresolved — no canonical attribution shown	$18.14	25.0%	1	2025
AstraZeneca Pharmaceuticals LP	Unresolved — no canonical attribution shown	$13.62	18.8%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$72.60	4

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
XIFAXAN Normalized: xifaxan	Drug	Salix Pharmaceuticals, a division of Bausch Health US, LLC	$40.84	2	2025
Source payment records 2025-01-21 · Salix Pharmaceuticals, a division of Bausch Health US, LLC · $23.19 · Open Payments source 2025-03-13 · Salix Pharmaceuticals, a division of Bausch Health US, LLC · $17.65 · Open Payments source
QULIPTA Normalized: qulipta	Drug	ABBVIE INC.	$18.14	1	2025
Source payment records 2025-01-07 · ABBVIE INC. · $18.14 · Open Payments source
FARXIGA Normalized: farxiga	Drug	AstraZeneca Pharmaceuticals LP	$13.62	1	2025
Source payment records 2025-01-06 · AstraZeneca Pharmaceuticals LP · $13.62 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
FARXIGA farxiga	2025	Farxiga	2024	268	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	LINZESS open payments reported associated product	CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608	Linzess · 2024 Exact normalized brand match · 1 Part D row	99	28
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	LUMIGAN open payments reported associated product	CMS Open Payments — General Payments 25016 supporting records · 7645 recipient NPIs · example record 1201352548	Lumigan · 2024 Exact normalized brand match · 1 Part D row	13	suppressed by CMS
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	SYNTHROID open payments reported associated product	CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636	Synthroid · 2024 Exact normalized brand match · 1 Part D row	38	suppressed by CMS
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	VRAYLAR open payments reported associated product	CMS Open Payments — General Payments 377741 supporting records · 62704 recipient NPIs · example record 1201352550	Vraylar · 2024 Exact normalized brand match · 1 Part D row	17	suppressed by CMS
AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference	2025	FARXIGA open payments reported associated product	CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362	Farxiga · 2024 Exact normalized brand match · 1 Part D row	268	31
AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference	2025	SYMBICORT open payments reported associated product	CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610	Symbicort · 2024 Exact normalized brand match · 1 Part D row	26	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Pantoprazole Sodium	Pantoprazole Sodium	1483	213
Gabapentin	Gabapentin	1455	243
Furosemide	Furosemide	1332	159
Atorvastatin Calcium	Atorvastatin Calcium	1246	239
Amlodipine Besylate	Amlodipine Besylate	1185	207
Levothyroxine Sodium	Levothyroxine Sodium	931	128
Potassium Chloride	Potassium Chloride	894	141
Losartan Potassium	Losartan Potassium	737	115
Eliquis	Apixaban	727	58
Trazodone Hcl	Trazodone Hcl	709	91
Metoprolol Succinate	Metoprolol Succinate	689	124
Omeprazole	Omeprazole	680	122
Famotidine	Famotidine	644	124
Lisinopril	Lisinopril	608	97
Rosuvastatin Calcium	Rosuvastatin Calcium	597	84
Donepezil Hcl	Donepezil Hcl	570	61
Buspirone Hcl	Buspirone Hcl	562	80
Tamsulosin Hcl	Tamsulosin Hcl	556	86
Metformin Hcl	Metformin Hcl	541	99
Memantine Hcl	Memantine Hcl	504	43
Glimepiride	Glimepiride	403	101
Pioglitazone Hcl	Pioglitazone Hcl	403	65
Pravastatin Sodium	Pravastatin Sodium	401	73
Escitalopram Oxalate	Escitalopram Oxalate	399	60
Metoprolol Tartrate	Metoprolol Tartrate	393	53
Sertraline Hcl	Sertraline Hcl	393	44
Ropinirole Hcl	Ropinirole Hcl	378	43
Clopidogrel	Clopidogrel Bisulfate	368	53
Montelukast Sodium	Montelukast Sodium	366	82
Carvedilol	Carvedilol	346	49
Mirtazapine	Mirtazapine	339	31
Quetiapine Fumarate	Quetiapine Fumarate	314	41
Hydrochlorothiazide	Hydrochlorothiazide	313	69
Duloxetine Hcl	Duloxetine Hcl	306	38
Citalopram Hbr	Citalopram Hydrobromide	296	44
Risperidone	Risperidone	284	23
Fluoxetine Hcl	Fluoxetine Hcl	280	27
Farxiga	Dapagliflozin Propanediol	268	31
Meloxicam	Meloxicam	263	84
Isosorbide Mononitrate Er	Isosorbide Mononitrate	259	22
Levetiracetam	Levetiracetam	259	17
Propranolol Hcl	Propranolol Hcl	250	28
Diclofenac Sodium	Diclofenac Sodium	245	71
Prednisone	Prednisone	241	149
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	228	51
Hydralazine Hcl	Hydralazine Hcl	222	28
Januvia	Sitagliptin Phosphate	222	25
Simvastatin	Simvastatin	221	48
Jardiance	Empagliflozin	220	31
Spironolactone	Spironolactone	219	25
Myrbetriq	Mirabegron	210	15
Cefdinir	Cefdinir	209	159
Allopurinol	Allopurinol	207	45
Midodrine Hcl	Midodrine Hcl	204	14
Oxybutynin Chloride	Oxybutynin Chloride	202	48
Albuterol Sulfate Hfa	Albuterol Sulfate	194	76
Megestrol Acetate	Megestrol Acetate	188	46
Ezetimibe	Ezetimibe	176	30
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	176	24
Olanzapine	Olanzapine	173	13
Warfarin Sodium	Warfarin Sodium	170	16
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	167	111
Sucralfate	Sucralfate	165	22
Ozempic	Semaglutide	163	38
Pregabalin	Pregabalin	163	45
Doxycycline Hyclate	Doxycycline Hyclate	162	90
Amitriptyline Hcl	Amitriptyline Hcl	155	28
Hydroxyzine Pamoate	Hydroxyzine Pamoate	155	39
Rivastigmine	Rivastigmine Tartrate	155	12
Xarelto	Rivaroxaban	154	12
Fluticasone Propionate	Fluticasone Propionate	153	57
Metformin Hcl Er	Metformin Hcl	149	44
Finasteride	Finasteride	142	16
Tizanidine Hcl	Tizanidine Hcl	142	25
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	142	28
Tramadol Hcl	Tramadol Hcl	136	76
Paroxetine Hcl	Paroxetine Hcl	133	22
Hydroxyzine Hcl	Hydroxyzine Hcl	131	29
Dicyclomine Hcl	Dicyclomine Hcl	129	18
Amiodarone Hcl	Amiodarone Hcl	128	11
Oxybutynin Chloride Er	Oxybutynin Chloride	128	14
Doxazosin Mesylate	Doxazosin Mesylate	126	suppressed
Naproxen	Naproxen	125	54
Olmesartan Medoxomil	Olmesartan Medoxomil	123	23
Ondansetron Hcl	Ondansetron Hcl	113	71
Rivastigmine	Rivastigmine	113	suppressed
Lorazepam	Lorazepam	112	31
Clonidine Hcl	Clonidine Hcl	108	23
Fluvoxamine Maleate	Fluvoxamine Maleate	104	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	103	suppressed
Primidone	Primidone	101	suppressed
Mupirocin	Mupirocin	100	55
Diltiazem Hcl	Diltiazem Hcl	99	13
Linzess	Linaclotide	99	28
Alendronate Sodium	Alendronate Sodium	97	14
Dexamethasone Sodium Phosphate	Dexamethasone Sodium Phosphate	97	61
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	97	49
Meclizine Hcl	Meclizine Hcl	96	45
Nifedipine Er	Nifedipine	96	13
Celecoxib	Celecoxib	95	19
Glipizide	Glipizide	95	13
Valproic Acid	Valproic Acid (As Sodium Salt)	95	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	91	26
Aripiprazole	Aripiprazole	90	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	84	28
Carbamazepine	Carbamazepine	83	suppressed
Lamotrigine	Lamotrigine	83	suppressed
Benztropine Mesylate	Benztropine Mesylate	82	11
Fenofibrate	Fenofibrate	78	12
Novolog Flexpen	Insulin Aspart	77	17
Bupropion Hcl Sr	Bupropion Hcl	75	24
Alprazolam	Alprazolam	74	17
Doxepin Hcl	Doxepin Hcl	74	suppressed
Trintellix	Vortioxetine Hydrobromide	74	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	73	suppressed
Bupropion Xl	Bupropion Hcl	71	16
Topiramate	Topiramate	71	suppressed
Clonazepam	Clonazepam	68	15
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	68	49
Paliperidone Er	Paliperidone	68	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	67	suppressed
Valsartan	Valsartan	67	19
Fluconazole	Fluconazole	66	54
Lacosamide	Lacosamide	66	suppressed
Atenolol	Atenolol	63	14
Esomeprazole Magnesium	Esomeprazole Magnesium	63	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	63	48
Benazepril Hcl	Benazepril Hcl	62	17
Mounjaro	Tirzepatide	62	13
Estradiol	Estradiol	61	19
Nystatin	Nystatin	57	31
Haloperidol	Haloperidol	56	suppressed
Levofloxacin	Levofloxacin	56	48
Clindamycin Hcl	Clindamycin Hcl	55	43
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	55	suppressed
Glyburide-Metformin Hcl	Glyburide/Metformin Hcl	54	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	54	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	53	14
Carbidopa-Levodopa	Carbidopa/Levodopa	53	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	53	suppressed
Divalproex Sodium	Divalproex Sodium	53	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	52	13
Probenecid	Probenecid	52	suppressed
Pyridostigmine Bromide	Pyridostigmine Bromide	52	suppressed
Tresiba Flextouch U-100	Insulin Degludec	52	12
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	51	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	50	16
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	50	14
Baclofen	Baclofen	49	16
Ondansetron Odt	Ondansetron	49	25
Venlafaxine Hcl Er	Venlafaxine Hcl	48	suppressed
Breo Ellipta	Fluticasone/Vilanterol	47	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	44	32
Promethazine Hcl	Promethazine Hcl	44	17
Aptiom	Eslicarbazepine Acetate	43	suppressed
Clotrimazole	Clotrimazole	43	23
Scopolamine	Scopolamine	43	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	42	32
Lansoprazole	Lansoprazole	42	suppressed
Austedo	Deutetrabenazine	41	suppressed
Calcium Acetate	Calcium Acetate	40	suppressed
Entresto	Sacubitril/Valsartan	40	suppressed
Cephalexin	Cephalexin	39	24
Diltiazem 24hr Er	Diltiazem Hcl	39	suppressed
Diltiazem 24hr Er (La)	Diltiazem Hcl	38	suppressed
Synthroid	Levothyroxine Sodium	38	suppressed
Temazepam	Temazepam	38	suppressed
Valacyclovir	Valacyclovir Hcl	37	21
Divalproex Sodium Er	Divalproex Sodium	36	suppressed
Lactulose	Lactulose	36	11
Azithromycin	Azithromycin	35	30
Calcitriol	Calcitriol	35	suppressed
Levemir	Insulin Detemir	35	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	35	13
Erythromycin	Erythromycin Base	34	21
Metolazone	Metolazone	34	27
Metronidazole	Metronidazole	34	27
Ceftriaxone	Ceftriaxone Sodium	33	28
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	33	suppressed
Latanoprost	Latanoprost	33	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	33	suppressed
Ranolazine Er	Ranolazine	33	suppressed
Dutasteride	Dutasteride	32	suppressed
Albuterol Sulfate	Albuterol Sulfate	31	16
Hydrocortisone	Hydrocortisone	31	14
Rexulti	Brexpiprazole	31	suppressed
Terbinafine Hcl	Terbinafine Hcl	31	21
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	30	11
Ketoconazole	Ketoconazole	30	14
Methocarbamol	Methocarbamol	30	suppressed
Propranolol Hcl Er	Propranolol Hcl	30	suppressed
Colchicine	Colchicine	29	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	29	suppressed
Lidocaine Hcl	Lidocaine Hcl/Pf	29	23
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	29	14
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	28	suppressed
Nabumetone	Nabumetone	28	suppressed
Olanzapine Odt	Olanzapine	28	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	27	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	26	suppressed
Levemir Flexpen	Insulin Detemir	26	12
Lithium Carbonate	Lithium Carbonate	26	suppressed
Symbicort	Budesonide/Formoterol Fumarate	26	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	25	22
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	25	suppressed
Gemtesa	Vibegron	25	suppressed
Irbesartan	Irbesartan	25	suppressed
Lovastatin	Lovastatin	25	suppressed
Novolog	Insulin Aspart	25	suppressed
Trulicity	Dulaglutide	25	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	25	suppressed
Clarithromycin	Clarithromycin	24	21
Doxycycline Monohydrate	Doxycycline Monohydrate	24	15
Vitamin D2	Ergocalciferol (Vitamin D2)	24	suppressed
Briviact	Brivaracetam	22	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	22	suppressed
Gentamicin Sulfate	Gentamicin Sulfate	22	14
Santyl	Collagenase Clostridium Hist.	22	12
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Humalog	Insulin Lispro	21	suppressed
Humalog Kwikpen U-100	Insulin Lispro	21	suppressed
Ipratropium Bromide	Ipratropium Bromide	20	suppressed
Methimazole	Methimazole	20	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	19	19
Amoxicillin	Amoxicillin	19	17
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	19	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	19	suppressed
Methylprednisolone	Methylprednisolone	19	18
Nitroglycerin	Nitroglycerin	19	16
Synjardy	Empagliflozin/Metformin Hcl	19	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	18	suppressed
Phenytoin	Phenytoin	18	suppressed
Solifenacin Succinate	Solifenacin Succinate	18	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	17	suppressed
Methenamine Mandelate	Methenamine Mandelate	17	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	17	suppressed
Vraylar	Cariprazine Hcl	17	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	16	suppressed
Folic Acid	Folic Acid	16	suppressed
Novolin N	Insulin Nph Human Isophane	16	suppressed
Terconazole	Terconazole	16	11
Verapamil Er	Verapamil Hcl	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Cilostazol	Cilostazol	15	suppressed
Dexlansoprazole Dr	Dexlansoprazole	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Tresiba Flextouch U-200	Insulin Degludec	15	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	14	suppressed
Humulin R	Insulin Regular, Human	14	suppressed
Morphine Sulfate	Morphine Sulfate	14	13
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	14	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Ertapenem	Ertapenem Sodium	13	suppressed
Eszopiclone	Eszopiclone	13	suppressed
Klor-Con M20	Potassium Chloride	13	suppressed
Lumigan	Bimatoprost	13	suppressed
Semglee (Yfgn)	Insulin Glargine-Yfgn	13	suppressed
Varenicline Tartrate	Varenicline Tartrate	13	suppressed
Xanax	Alprazolam	13	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	13	suppressed
Zonisamide	Zonisamide	13	suppressed
Arformoterol Tartrate	Arformoterol Tartrate	12	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Diazepam	Diazepam	12	suppressed
Neomycin-Polymyxin-Hc	Neomycin/Polymyxin B/Hydrocort	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Verapamil Er Pm	Verapamil Hcl	12	suppressed
Asenapine Maleate	Asenapine Maleate	11	suppressed
Dapagliflozin	Dapagliflozin Propanediol	11	suppressed
Haloperidol Decanoate	Haloperidol Decanoate	11	suppressed
K-Phos Original	Potassium Phosphate,monobasic	11	suppressed
Ketorolac Tromethamine	Ketorolac Tromethamine	11	11
Nitrofurantoin	Nitrofurantoin Macrocrystal	11	suppressed
Novolin R	Insulin Regular, Human	11	suppressed
Prednisolone Acetate	Prednisolone Acetate	11	suppressed
Premarin	Estrogens, Conjugated	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$72.60 · 4 records	Salix Pharmaceuticals, a division of Bausch Health US, LLC	FARXIGA, QULIPTA, XIFAXAN	6	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Farxiga play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error